, wherein n is an integer chosen from 1, 2, 3, 4, and 5, and R2 is H or methyl. At least one described molecular species exhibits an IC50 value below 5 μM against human pancreatic cancer cells in vitro. Administration of this species promoted shrinkage of pancreatic cancer tumors in a murine model system in vivo. It led to a 100% survival of experimental animals over a time course in which control therapies provided only 30% or 40% survival. Methods of synthesis of molecular species are also disclosed."/>
公开/公告号US10975069B2
专利类型
公开/公告日2021-04-13
原文格式PDF
申请/专利权人 WASHINGTON UNIVERSITY;
申请/专利号US201916426791
申请日2019-05-30
分类号C07D451/14;A61K31/517;A61P35;C07D471/08;A61K31/496;A61K45/06;
国家 US
入库时间 2022-08-24 18:11:20